Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q2

7776.TEDINET S100OZ8N
Period2022-01-01 → 2022-06-30
Filed2022-08-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 28
MetricValuePeriodScopeSource row
Revenue¥75m2022-01-01 → 2022-06-30StandaloneNet sales
Revenue¥162m2021-01-01 → 2021-12-31StandaloneNet sales (5-year summary)
Operating income−¥349m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥353m2022-01-01 → 2022-06-30StandaloneOrdinary income
Ordinary income−¥866m2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Profit before tax−¥355m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥357m2022-01-01 → 2022-06-30StandaloneProfit loss
Net income−¥913m2021-01-01 → 2021-12-31StandaloneNet income loss (5-year summary)
Total assets¥1.7bnat 2022-06-30StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneAssets
Total liabilities¥396mat 2022-06-30StandaloneLiabilities
Total liabilities¥364mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.3bnat 2022-06-30StandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31StandaloneNet assets
Cash and deposits¥1.2bnat 2022-06-30StandaloneCash and deposits
Cash and deposits¥847mat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.2bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥847mat 2021-12-31StandaloneCash and cash equivalents
Operating cash flow−¥269m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥15m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥606m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-18.542022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.752022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.082021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Equity ratio75.1%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued22,159,419at 2022-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued17,759,419at 2021-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 10
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥100m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-06-30−¥208m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-06-30−¥41m
—segment totalrevenue2022-01-01 → 2022-06-30¥75m
—segment totalrevenue external2022-01-01 → 2022-06-30¥75m
—segment totalsegment profit2022-01-01 → 2022-06-30−¥248m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 331
ItemContextValueUnit
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember1986000JPY
Commission fee noiCurrentYTDDuration_NonConsolidatedMember175000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember21000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember2189000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember418000JPY
Stock issuance cost prior noeCurrentYTDDuration_NonConsolidatedMember5705000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember6124000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-352779000JPY
Impairment loss elCurrentYTDDuration_NonConsolidatedMember2445000JPY
Extraordinary lossCurrentYTDDuration_NonConsolidatedMember2445000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-355225000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1900000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1900000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-357125000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-355225000JPY
Depreciation and amortization ope cfCurrentYTDDuration_NonConsolidatedMember3932000JPY
Impairment loss ope cfCurrentYTDDuration_NonConsolidatedMember2445000JPY
Interest income ope cfCurrentYTDDuration_NonConsolidatedMember-5000JPY
Interest expenses ope cfCurrentYTDDuration_NonConsolidatedMember418000JPY
Share based compensation expenses ope cfCurrentYTDDuration_NonConsolidatedMember798000JPY
Stock issuance cost prior ope cfCurrentYTDDuration_NonConsolidatedMember5705000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYTDDuration_NonConsolidatedMember2113000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember-20689000JPY
Decrease increase in other current assets ope cfCurrentYTDDuration_NonConsolidatedMember49394000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYTDDuration_NonConsolidatedMember5320000JPY
Increase decrease in accounts payable other ope cfCurrentYTDDuration_NonConsolidatedMember-42814000JPY
Increase decrease in advances received ope cfCurrentYTDDuration_NonConsolidatedMember30772000JPY
Increase decrease in provision for bonuses ope cfCurrentYTDDuration_NonConsolidatedMember-509000JPY
Increase decrease in other current liabilities ope cfCurrentYTDDuration_NonConsolidatedMember53225000JPY
Subtotal ope cfCurrentYTDDuration_NonConsolidatedMember-265117000JPY
Interest income received ope cfCurrentYTDDuration_NonConsolidatedMember4000JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration_NonConsolidatedMember-480000JPY
Income taxes paid ope cfCurrentYTDDuration_NonConsolidatedMember-3798000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration_NonConsolidatedMember-269391000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration_NonConsolidatedMember-14931000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration_NonConsolidatedMember-14931000JPY
Proceeds from issuance of stock resulting from exercise of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember604538000JPY
Proceeds from issuance of subscription rights to shares fin cfCurrentYTDDuration_NonConsolidatedMember1144000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration_NonConsolidatedMember605682000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration_NonConsolidatedMember321358000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember846674000JPY
Cash and cash equivalentsCurrentQuarterInstant_NonConsolidatedMember1168032000JPY
Directors compensations sgaCurrentYTDDuration_NonConsolidatedMember20772000JPY
Salaries and allowances sgaCurrentYTDDuration_NonConsolidatedMember50269000JPY
Bonuses sgaCurrentYTDDuration_NonConsolidatedMember10153000JPY
Provision for bonuses sgaCurrentYTDDuration_NonConsolidatedMember2150000JPY
Compensations sgaCurrentYTDDuration_NonConsolidatedMember12834000JPY
License fee sgaCurrentYTDDuration_NonConsolidatedMember8890000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember70188000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-06-30pass